This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Greenblatt, D. J. Articles by Huffman, D. H. Search for Related Content PubMed PubMed Citation Articles by Greenblatt, D. J. Articles by Huffman, D. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PROPRANOLOL HYDROCHLORIDE

Circulation, Vol 57, 1161-1164, Copyright © 1978 by American Heart Association

ARTICLES

Impairment of antipyrine clearance in humans by propranolol

DJ Greenblatt, K Franke and DH Huffman

The effect of propranolol on antipyrine clearance in humans was evaluated in six healthy volunteers who received single 1.4 to 1.5 g doses of intravenous antipyrine on two occasions. The first (control) antipyrine trial was without concurrent drug administration; the second trial was done during treatment with therapeutic doses of propranolol (40 mg every 4 to 6 hours). Antipyrine elimination half-life (t1/2), volume of distribution (Vd), and total clearance were determined after each trial. In all subjects isoproterenol sensitivity decreased markedly during propranolol treatment, indicating a high degree of beta blockade produced by the drug. Mean antipyrine t1/2 during the propranolol treatment period was significantly prolonged, and total clearance significantly reduced, over the control values. Twenty-four- hour urinary excretion of 4-hydroxyantipyrine, the major metabolite of antipyrine, likewise was reduced from 23.6% of the dose on the control trial to 14.8% of the dose during propranolol coadministration (0.1 less than P less than 0.2). Vd however, was nearly identical during both trials (0.62 L/kg). Thus propranolol prolongs the half-life and reduces the clearance or biotransformation rate of antipyrine, a drug whose clearance is independent of hepatic blood flow. Propranolol may influence the activity of hepatic microsomal enzymes responsible for drug hydroxylation.

This article has been cited by other articles:

				A. Mooradian, J. E. Morley, G. Simon, and R. B. Shafer Propranolol-Induced Hyperthyroxinemia Arch Intern Med, November 1, 1983; 143(11): 2193 - 2195. [Abstract] [PDF]